DC

Deshal Chirag Shah

Active Director Director DIN 07903611
DIN 07903611 First appointment Aug 2017 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Aug 2017
Shareholding value •••• Premium profile

About Deshal Chirag Shah

Data last updated:

Deshal Chirag Shah has 9 years in corporate governance. Holds Director and Nominee Director roles. Currently with 3 companies, including Accumax Lab Devices Private Limited and Accumax Lab Devices Private Limited. Formerly with 4 companies, such as Genefact Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹285 Cr; the largest is Accumax Lab Devices Private Limited at ₹256 Cr (FY 2025).

DIN 07903611
Primary Designation Director
First Appointment 31 Aug 2017
Oldest Company Age 17 yrs
Largest company Accumax Lab Devices Private Limited · ₹256 Cr (FY 2025)
Combined revenue ₹285 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Accumax Lab Devices Private Limited U33110GJ2009PTC056957
Director01 Aug 20182009₹256 Cr (FY 2025)Active
Sterilem Private Limited U46596GJ2025PTC157677
Nominee Director06 Jan 20252025₹26.18 Cr (FY 2026)Active
Aakashi Colorants Private Limited U24100GJ2022PTC136153
Director29 Dec 20232022₹2.25 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genefact Private Limited U24290GJ2022PTC136995
Director25 Nov 20222022–Amalgamated
Accumax Lab Devices Private Limited U33125GJ2017PTC099233
Director26 Sep 20172017–Amalgamated
Director31 Aug 20172017–Amalgamated
Firstcare Biosystem Private Limited U33309GJ2017PTC099229
Director25 Sep 20172017–Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Accumax Lab Devices Private Limited
Accumax Lab Devices Private Limited
Fine Care Corporation Private Limited
Firstcare Biosystem Private Limited
Premium access

Shareholding and investment profile for Deshal Chirag Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deshal Chirag Shah

Deshal Chirag Shah has 9 years in corporate governance. Holds Director and Nominee Director roles. Currently with 3 companies, including Accumax Lab Devices Private Limited and Accumax Lab Devices Private Limited. Formerly with 4 companies, such as Genefact Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹285 Cr; the largest is Accumax Lab Devices Private Limited at ₹256 Cr (FY 2025).

Deshal Chirag Shah is associated with 3 companies as Director and Nominee Director, including Accumax Lab Devices Private Limited (₹256 Cr), Sterilem Private Limited (₹26.18 Cr), Aakashi Colorants Private Limited (₹2.25 Cr).

Deshal Chirag Shah has expertise in General Business.

Deshal Chirag Shah has 9 years in corporate governance.

By reported revenue, the largest current company of Deshal Chirag Shah is Accumax Lab Devices Private Limited, with revenue of ₹256 Cr (FY 2025).

The 3 current companies of Deshal Chirag Shah that report revenue have a combined latest revenue of ₹285 Cr.

Deshal Chirag Shah currently holds positions at 3 companies: Accumax Lab Devices Private Limited (₹256 Cr), Sterilem Private Limited (₹26.18 Cr), Aakashi Colorants Private Limited (₹2.25 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available